Q-1064 , 45th Parliament, 1st session May 26, 2025, to present

With regard to government information about and funding for PrescribeIT: (a) how much federal funding was (i) allocated, (ii) spent, broken down by direct funding and indirect funding provided through the Canada Health Infoway; (b) what were the stated objectives, performance targets, and adoption benchmarks of the program, and to what extent were they met; (c) according to the best information available to the government, how many healthcare providers registered to use PrescribeIT and, of those, how many were actively using the system, broken down by province and territory; (d) what percentage of prescriptions in Canada were transmitted through PrescribeIT (i) at its peak, (ii) at the time of its discontinuation; (e) which specific government ministers and officials (i) proposed, (ii) approved, Prescribe IT broken down by date, type of approval, and which part of the development process each approved; (f) what are the details, including dates, methodology and findings, of all research, feasibility studies, cost-benefit analyses, or pilot evaluations conducted prior to the approval and rollout of the program; (g) what internal audits, evaluations, or third-party reviews have been conducted on PrescribeIT, and will the government make those reports public; and (h) what steps, if any, have been taken to hold individuals or organizations accountable for the outcomes of the program or to recover any of the money lost?